Healthcare sector | Medical Instruments & Supplies industry
| Price | $10.54 |
|---|---|
| Shares Outstanding | 3.56M |
| All-Time Low | $2.73 |
| 52-Week Low | $2.73 |
| Net Cash / Share | $0 |
|---|---|
| Net Current Assets / Share | $0.83 |
| Net Tangible Assets / Share | $1.43 |
| Shares Outstanding Ave Change (Annual) | 20.49% |
| Shares Δ YoY | 49.54% |
| Avg CA Burn (Annual %) | -25.57% (as of 3-8-2026) |
| Avg CA Burn (Quarterly %) | -6.58% (as of 3-8-2026) |
| Max Earning Power / Share | $-10.87 |
|---|---|
| Adjusted Earning Power |
$-12.49
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
1.09%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 0 (as of 3-8-2026) |
| Avg EBITDA (5Q) | 0 (as of 3-8-2026) |
| Avg Net Income (5Y) | -12.8M (as of 3-8-2026) |
| Avg Net Income (5Q) | -3M (as of 3-8-2026) |
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 3-8-2026 |
| Consecutive Years Paid | No | 3-8-2026 |
| Pays Dividend | No | 3-8-2026 |
| Last Dividend Date | 3-24-20 | |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | No | 3-8-2026 |
| Net Income Positive | No | 3-8-2026 |
| Current Dividend Streak | No | 3-8-2026 |
Pick a metric to view its history table and chart.
Formula: Tangible Book Value / shares from balance statements. Includes 6 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-12-31 | Quarterly | $1.43 | 5.1M ($5,096,000) | 3.6M (3,559,000) |
| 2025-09-30 | Quarterly | $1.94 | 5.1M ($5,096,000) | 2.6M (2,623,000) |
| 2025-06-30 | Quarterly | $2.40 | 6.3M ($6,264,000) | 2.6M (2,605,000) |
| 2025-03-31 | Quarterly | $4.23 | 7.9M ($7,944,000) | 1.9M (1,879,779) |
| 2024-12-31 | Quarterly | $5.20 | 7.7M ($7,696,000) | 1.5M (1,480,200) |
| 2024-12-31 | Annual | $5.20 | 7.7M ($7,696,000) | 1.5M (1,480,200) |
| 2024-09-30 | Quarterly | $6.67 | 9.8M ($9,777,000) | 1.5M (1,466,533) |
| 2023-12-31 | Annual | $7.36 | 7.3M ($7,283,000) | 989.9K (989,866) |
| 2022-12-31 | Annual | $22.49 | 19.8M ($19,794,000) | 880.2K (880,200) |
| 2021-12-31 | Annual | $43.98 | 37.2M ($37,219,000) | 846.2K (846,200) |
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2024-12-31 | 17.9M ($17,925,000) |
| 2023-12-31 | 18.3M ($18,279,000) |
| 2022-12-31 | 12.9M ($12,912,000) |
| 2021-12-31 | 11.2M ($11,246,000) |
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-03-02 | 3,563,381 | +229 |
| 2026-01-26 | 3,563,152 | +170,429 |
| 2026-01-22 | 3,392,723 | +769,490 |
| 2025-10-31 | 2,623,233 | +11,445 |
| 2025-09-19 | 2,611,788 | -2 |
| 2025-08-04 | 2,611,790 | +245,120 |
Latest short-interest change: 247,981 shares (7.05% of float) | Days to cover: 1.55
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-03-12 | 247,981 shares | -31,379 | -11.23% |
| 2026-02-27 | 279,360 shares | +53,984 | +23.95% |
| 2026-02-11 | 225,376 shares | -80,374 | -26.29% |
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| 2026-01-06 | 960,537 | 2,623,233 | 36.62% | $9.53 |
| 2026-01-05 | 762,306 | 2,623,233 | 29.06% | $8.55 |
| 2026-01-02 | 1,203,228 | 2,623,233 | 45.87% | $7.84 |
| 2025-12-31 | 3,662,015 | 2,623,233 | 139.60% | $8.64 |
| 2025-12-30 | 109,228,442 | 2,623,233 | 4163.89% | $10.58 |
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EVO, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. It also offers EksoCare offering an extended warranty and premium service options, repairs and maintenance services, and training programs. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.